What Does an ANA Pattern Mitotic Spindle Fibers Mean?

An ANA pattern reported as “mitotic spindle fibers” (sometimes called “mitotic spindle apparatus” or MSA) means your blood contains antibodies that target the machinery cells use to divide. It is one of the rarest patterns that can show up on an antinuclear antibody test, and it does not point to a single diagnosis. In some people it accompanies a connective tissue disease like Sjögren syndrome, rheumatoid arthritis, or lupus, while in others it appears with no clear autoimmune condition at all. Understanding what this pattern actually represents, how uncommon it is, and what clinicians do with it can save you a good deal of confusion when you see it on a lab report.

What the ANA Test Is Actually Showing

When a lab runs an ANA test, it exposes a slide of human cells to your serum and looks for antibodies that stick to structures inside those cells. The cells on the slide are in various stages of their life cycle, and some of them are caught in the act of dividing. During cell division, a structure called the mitotic spindle forms to pull chromosomes apart so each new daughter cell gets the right set. When the lab sees your antibodies lighting up that spindle structure in dividing cells, the result is reported as a mitotic spindle apparatus (MSA) pattern.

What makes this pattern distinctive is that the staining is most visible in cells that are actively dividing. Cells sitting quietly between divisions may look negative or only faintly positive, while mitotic cells glow brightly along the spindle fibers that stretch between the two poles of the dividing cell. That contrast is the hallmark of the pattern and the reason it can be tricky to catch if the technologist reading the slide does not look specifically at dividing cells.

The Proteins These Antibodies Target

The mitotic spindle is not one molecule. It is a complex assembly of proteins, and your antibodies may be directed at any of several components. The most common target is a large protein called Nuclear Mitotic Apparatus protein, usually abbreviated NuMA. NuMA helps organize the poles of the spindle and is by far the autoantigen identified most often when patients test positive for this pattern.¹

A second well-characterized target is a motor protein called HsEg5, a kinesin-like protein that walks along microtubules to push the two halves of the spindle apart. In one study examining sera from patients who showed an MSA staining pattern, about 14% reacted specifically with HsEg5, and most of those patients had systemic lupus erythematosus.² Other potential spindle targets exist, including centrosome-associated proteins and CENP-F, a protein involved in the connection between chromosomes and the spindle fibers, but NuMA and HsEg5 account for the majority of well-studied cases.

Knowing which specific protein the antibodies target matters because different sub-patterns can carry different disease associations. Laboratories that go beyond the initial fluorescence pattern and perform confirmatory testing, such as immunoblotting, can sometimes nail down the exact target and give clinicians a more refined picture of what the result means.³

How Rare This Pattern Really Is

If you have this result, you are in a very small club. In a large Chinese study that screened over 180,000 patients for ANA, roughly 38% tested ANA-positive overall, but only 32 patients, or about 0.018%, showed the mitotic spindle pattern.⁴ A separate review of over 113,000 tested patients found that uncommon or rare ANA patterns appeared in about 1.3% of positive results, with MSA patterns making up the largest share of that uncommon group, at 592 cases.⁵ A third, smaller study put the mitotic spindle pattern at just under 1% of all ANA-positive results, with a higher prevalence in women than in men.⁶

The rarity itself is part of the problem. Because most clinicians and even many lab technologists encounter this pattern infrequently, it can go unrecognized or be misreported as a different pattern. The process of reading ANA slides under a fluorescence microscope is inherently subjective, and studies on inter-observer agreement show that even experienced technologists sometimes disagree on uncommon patterns like MSA.⁷ If you receive a report mentioning mitotic spindle fibers, you can be fairly confident the lab was looking carefully, because it is easy to miss rather than easy to over-call.

Disease Associations

A mitotic spindle ANA pattern does not equal a diagnosis. In the large study of 592 MSA-positive patients where complete clinical data were available for 329, only about a third had an established autoimmune diagnosis at the time the antibody was found. Among those who did have a diagnosis, the most frequent conditions were Sjögren syndrome (about 18%), rheumatoid arthritis (about 14%), and systemic lupus erythematosus (about 11%).⁵ The Chinese cohort of 32 MSA-positive patients followed a similar ranking, with Sjögren syndrome and rheumatoid arthritis leading the list among those with connective tissue diseases.⁴

Lupus deserves a separate mention because the HsEg5 sub-pattern appears to cluster there. In the study that identified HsEg5 as an autoantigen, six of the seven patients with anti-HsEg5 antibodies had lupus, with the remaining patient having Sjögren syndrome.² That is a small sample, but the skew toward lupus was striking enough that researchers flagged HsEg5 as a potential lupus-associated autoantigen worth investigating further.

The broader point for patients is that having an MSA pattern raises the possibility of an underlying connective tissue disease but does not confirm one. Roughly half of the patients with anti-MSA antibodies in the large study had a connective tissue disease of some kind, while the other half did not.

Surprising Non-Rheumatic Associations

Some of the more interesting findings around the MSA pattern involve conditions that are not classic autoimmune or rheumatic diseases. The same large study that described Sjögren syndrome and rheumatoid arthritis as the leading diagnoses also found a statistically significant association between the NuMA sub-pattern and chronic idiopathic urticaria, a condition involving persistent hives without a clear allergic trigger. Sensorineural hearing loss also showed up as a significant association with certain MSA sub-patterns, which had not been reported before.⁵

These are early observations and they need replication, but they hint that anti-MSA antibodies may pop up in a broader range of conditions with autoimmune features than the textbook list of lupus, Sjögren, and rheumatoid arthritis would suggest. The study’s authors specifically noted that other conditions of “presumed autoimmune origin,” like chronic hives and certain forms of hearing loss, might belong in the clinical picture when these patterns are found.

In the Chinese study, six of the 32 MSA-positive patients had non-autoimmune diagnoses entirely, meaning conditions where autoimmunity was not the underlying problem at all.⁴ This reinforces the idea that finding the pattern on a lab slip does not automatically place you in the autoimmune category.

Why the Pattern Often Stands Alone

One of the more unusual features of anti-MSA antibodies is how often they are the only autoantibody a patient has. In the large study, anti-MSA antibodies behaved as “monospecific,” meaning they were the sole positive ANA finding in about 81% of patients.⁵ The Chinese cohort reported a similar figure, with about 70% of MSA-positive patients having no other ANA-specific antibodies detected.⁴

This matters for how your doctor interprets the result. Many autoimmune diseases are diagnosed partly by finding a cluster of characteristic antibodies. If someone with suspected lupus has anti-double-stranded DNA and anti-Smith antibodies along with a positive ANA, the picture is relatively clear. But when the MSA pattern is the only thing that turns up, there is no supporting serologic evidence pointing toward a specific disease. When additional antibodies were present alongside anti-MSA, anti-Ro (also called anti-SSA) was the most common companion, found in about 15% of those who had any further reactivity at all. Anti-Ro itself is associated with Sjögren syndrome and lupus, so its presence in this context fits with the known disease associations.

For you as a patient, the monospecific nature of these antibodies means that a positive MSA result often leads to a clinical evaluation rather than a clear-cut serologic diagnosis. Your doctor will likely rely more heavily on your symptoms, physical examination, and other lab work to decide whether a connective tissue disease is actually present.

The Challenge of Reading This Pattern Correctly

Reading ANA slides by fluorescence microscopy is part science and part craft. The technologist has to scan a field of cells, identify the ones that are dividing, and then characterize the staining pattern in those mitotic cells versus the resting ones. For common patterns like homogeneous or speckled staining, the visual cues are well known and easy to teach. For rare patterns like MSA, the staining is subtle and many technologists may have seen it only a handful of times in their career.

Research on automated pattern recognition has confirmed what laboratorians already know from experience. The process is subjective, time-consuming, and influenced by individual bias and experience level. Disagreements between skilled technologists are common, and the rarity of the MSA pattern contributes to unacceptable rates of misclassification.⁷ Some laboratories have begun using computer-assisted image analysis to help flag mitotic cells and classify staining patterns, and early results suggest these systems can outperform manual reading for fine-grained pattern recognition. But most clinical labs still rely on experienced human eyes, and the consistency of MSA identification remains an acknowledged weak point.

If you receive an MSA result from a lab that does high-volume ANA testing and has specific expertise in uncommon patterns, you can place more confidence in the reading than if it comes from a small lab that rarely encounters it. When there is clinical doubt, some rheumatologists will request that the slide be reviewed by a reference laboratory or that confirmatory testing, such as immunoblotting for NuMA or HsEg5, be performed.

What Happens After You Get This Result

A positive MSA pattern on its own does not demand treatment. The antibody finding is a clue, not a disease. What your doctor does with it depends almost entirely on the clinical context. If you were tested because of joint pain, dry eyes, rashes, or other symptoms suggestive of autoimmune disease, the MSA result adds a piece of circumstantial evidence, and your doctor will likely pursue further evaluation. That might include specific antibody panels for Sjögren syndrome or lupus, imaging of the salivary glands, or referral to a rheumatologist if you are not already seeing one.

If the ANA was ordered as part of a general workup and you have no symptoms that suggest autoimmune disease, the MSA finding becomes harder to interpret. Because a substantial number of MSA-positive patients end up having no identifiable autoimmune condition, a positive test in someone who feels well may simply warrant periodic monitoring rather than an aggressive diagnostic push. Autoantibodies can precede clinical disease by years, but they can also be present for a lifetime without ever causing trouble.

The monospecific behavior of anti-MSA antibodies, as described above, means that a full ANA sub-panel (sometimes called an extractable nuclear antigen, or ENA panel) will often come back negative. That can be reassuring in one sense, as it makes specific diagnoses like lupus less likely, but it can also be frustrating because it leaves the question open. The presence of anti-Ro antibodies alongside the MSA pattern would tilt the clinical picture toward Sjögren syndrome and warrant a more focused investigation of dry-eye and dry-mouth symptoms, salivary gland function, and sometimes biopsy.

Spindle Errors, Cancer, and What Anti-MSA Does Not Tell You

When people see the words “mitotic spindle” on their lab report, they sometimes worry about cancer, because cell division is so closely associated with tumor growth. The mitotic spindle is indeed critical for accurate cell division, and errors in spindle formation have been linked to chromosomal instability, which can contribute to tumor development.⁸ But that connection is about the spindle’s function inside your own cells, not about the antibodies directed at spindle proteins.

Having anti-MSA antibodies means your immune system recognizes spindle proteins as foreign. It does not mean the spindle is malfunctioning in your cells, and it is not a cancer marker. Some autoantibodies do occur more frequently in certain malignancies, but the available data on anti-MSA do not position it as a reliable cancer-associated autoantibody. The large studies on MSA patterns focus on connective tissue diseases and conditions like chronic hives and hearing loss, not malignancy. If your doctor ordered the ANA because of cancer screening or concern, the MSA pattern is unlikely to contribute useful information on that front.

Gender, Age, and Who Gets This Pattern

Like most autoantibodies and most autoimmune diseases, the MSA pattern is seen more often in women. One study found a clear female predominance among patients with uncommon ANA patterns including MSA.⁶ This tracks with the broader observation that autoimmune conditions disproportionately affect women, likely due to hormonal and genetic factors on the X chromosome that influence immune regulation.

There is limited published data on the MSA pattern in children. The large studies that characterize the clinical associations and prevalence were conducted in adult populations, and pediatric autoimmune disease tends to present differently from adult disease in many respects. If a child receives an MSA result, interpretation should involve a pediatric rheumatologist familiar with the nuances of ANA testing in younger patients, where positive results are relatively common and often transient without signaling serious disease.

Age also affects ANA positivity in general. Healthy older adults are more likely to have low-titer positive ANAs than younger adults, and this background positivity can complicate interpretation. Whether age influences the likelihood of an MSA pattern specifically is not well characterized in the current literature, so the general advice applies: context matters more than the antibody alone.

1
Autoantibodies. Mitotic Spindle Apparatus Autoantibodies
2
PubMed. The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus
3
PubMed. Antibodies to mitotic spindle apparatus: clinical significance of NuMA and HsEg5 autoantibodies
4
PubMed Central. Anti-Mitotic Spindle Apparatus Antoantibodies: Prevalence and Disease Association in Chinese Population
5
PubMed Central. Uncommon patterns of antinuclear antibodies recognizing mitotic spindle apparatus antigens and clinical associations
6
Clinical Biochemistry. Uncommon antinuclear antibody patterns as diagnostic indicators
7
Briefings in Bioinformatics. Recognition of rare antinuclear antibody patterns based on a novel attention-based enhancement framework
8
PubMed Central. New Roles of Chk1 in Spindle Formation and Genome Integrity